Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02584088 · ClinicalTrials.gov registry record
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
A clinical trial of Menorrhagia, sponsored by TriHealth.
- Completed
- Registry status
- 80
- Enrollment target
- 2
- Study locations
NCT02584088 is a study of Menorrhagia that has completed, run by TriHealth. The registered enrollment target is 80 participants, below the 221-participant average among 10 other Menorrhagia trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02584088, a study of Menorrhagia, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
* The study primarily aims to evaluate the post ablative endometrium and uterus using transvaginal ultrasound to provide descriptive information as to what may be expected in the 12 months after a NovaSure ablation. Investigators believe this knowledge will help them to determine when to proceed with further evaluation postoperatively or when to counsel patients on expectant management based on ultrasonographic findings. * Secondary aims include correlation of ultrasonographic findings to demographic patient data.
Conditions Studied
Interventions
- OTHER Ultrasound
Study Locations (2)
Ohio
- Good Samaritan Hospital - Cincinnati
- Bethesda North Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-10-11 |
| Est. Completion | 2021-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02584088
The ClinicalTrials.gov registry entry for NCT02584088 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 10 other Menorrhagia trials with a reported enrollment target (64% lower). The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menorrhagia appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT02584088 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02584088 about?
NCT02584088 is a clinical study titled "Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation". * The study primarily aims to evaluate the post ablative endometrium and uterus using transvaginal ultrasound to provide descriptive information as to what may be expected in the 12 months after a NovaSure ablation. Investigators believe this knowledge will help them to determine when to proceed wit...
What is the current status of trial NCT02584088?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2016-10-11. Estimated completion is 2021-11.
What conditions does trial NCT02584088 study?
This clinical trial studies the following conditions: Menorrhagia.
What interventions are being tested in trial NCT02584088?
The interventions under investigation include: Ultrasound (OTHER).
Who is sponsoring clinical trial NCT02584088?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02584088 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menorrhagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
RECRUITING
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
COMPLETED · NA
-
Efficacy and Safety Study of XP12B in Women With Menorrhagia
COMPLETED · Phase 3
-
A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding
COMPLETED · Phase 3
-
Hysteroscopic Assessment of Fallopian Tubal Patency
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.